Early Structural, Biochemical, and Metabolic Response to Anlotinib in Patients with Progressive Radioactive Iodine Refractory Differentiated Thyroid Cancer
Endocrine Practice(2024)
Key words
radioactive iodine refractory,differentiated thyroid cancer,multikinase inhibitor,anlotinib,F-18-FDG-PET/CT,early response
AI Read Science
Must-Reading Tree
Example

Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined